Completed PHASE2 INTERVENTIONAL 4-arm NCT06214052

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

A Phase 2a, Randomized, Double-Blind (Sponsor Unblinded), Placebo-Controlled, Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH4524184 in HIV-1 Infected Treatment Naïve Adults

Sponsor: GlaxoSmithKline

Conditions HIV Infections

Interventions Antiretroviral therapy Matching Placebo VH4524184

Updated 8 times since 2024 Last updated: Jun 12, 2025 Started: Feb 7, 2024 Primary completion: Jun 12, 2024 Completion: Jun 12, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06214052, this PHASE2 trial focuses on HIV Infections and remains completed. Sponsored by GlaxoSmithKline, it has been updated 8 times since 2024, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Jul 2025 — Sep 2025 [monthly]

Completed PHASE2
Oct 2024 — Jul 2025 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Mar 2024 — Jun 2024 [monthly]

Not Yet Recruiting PHASE2
Feb 2024 — Mar 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline
ViiV Healthcare

Data source: ViiV Healthcare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bakersfield, United States , Barcelona, Spain , Buenos Aires, Argentina , Ciudad Autonoma de Bueno, Argentina , DeLand, United States , Elche Alicante, Spain , Los Angeles, United States , Madrid, Spain , Milan, Italy , Montreal, Canada and 5 more locations